🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hypertrophic Cardiomyopathy

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Transapical Beating-heart Septal Myectomy in Patient With Hypertrophic Obstructive Cardiomyopathy NCT05332691NA1 site📍 Wuhan Xiang Wei · Tests: Transapical beating-heart septal myectomy Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia NCT05302271Phase 11 site📍 New York Weill Medical College of Cornell University · Tests: AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN… Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases NCT07464132Phase 1, Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Injection of 68Ga-NI-FAPI Austrian Hypertrophic Cardiomyopathy Registry NCT06368518n/a15 sites📍 Linz📍 Sankt Pölten📍 Wiener Neustadt Medical University of Graz AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor NCT06699056n/a8 sites📍 Orange📍 Pasadena📍 Detroit Peerbridge Health, Inc · Tests: 15-minutes of sitting during COR ECG Acquistion ATR 1072 in Participants With PRKAG2 Syndrome NCT07738107Phase 1, Phase 21 site📍 Kansas City Atrium Therapeutics · Tests: ATR 1072 Exercise Prescription in Children With Hypertrophic Cardiomyopathy NCT07595354NA1 site📍 Liverpool Alder Hey Children's NHS Foundation Trust · Tests: Exercise Prescription Valsalva SBP Drop and LVOT Obstruction NCT07483125n/a1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: participants are not assigned an intervention as part of the study Molecular and Imaging Studies of Cardiovascular Health and Disease NCT02804269n/a1 site📍 Singapore National Heart Centre Singapore · Tests: Cardiovascular Magnetic Resonance, Fatmass measurement Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy NCT07150299n/a1 site📍 Vienna Medical University of Vienna · Tests: Mavacamten in clinical routine use Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy NCT05569382Phase 44 sites📍 Aarhus N📍 Odense📍 Roskilde Morten Steen Kvistholm Jensen · Tests: Verapamil, Bisoprolol, Placebo LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain. NCT07202897Phase 317 sites📍 Angers📍 Bordeaux📍 Brest Rennes University Hospital · Tests: Anticoagulant treatment Rivaroxaban, Best medical therapy A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease NCT06092034Phase 26 sites📍 La Jolla📍 Boston📍 Philadelphia Rocket Pharmaceuticals Inc. · Tests: RP-A501 The Application of T1 Mapping in Real-World NCT07354646n/a1 site📍 Beijing Chinese Academy of Medical Sciences, Fuwai Hospital · Tests: Magnetic Resonance Imaging with Contrast Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM) NCT07541833n/a1 site📍 Minato-ku Bristol-Myers Squibb · Tests: Mavacamten Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan NCT07383025n/a1 site📍 Tokyo Bristol-Myers Squibb · Tests: Mavacamten Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM) NCT07344480n/a1 site📍 München Deutsches Herzzentrum Muenchen · Tests: Retrospective data collection Cardiovascular Multimodality Imaging Study NCT06610019n/a1 site📍 The Bronx Montefiore Medical Center AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy NCT07263204n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy NCT06730464n/a4 sites📍 Milan📍 Lispon📍 Barcelona Centro Medico Teknon Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition NCT06409585n/a1 site📍 Edinburgh University of Edinburgh · Tests: 68Ga-FAPI or 18F-AlF-FAPI cardiac PET-MR, Echocardiogram, Cardiac MRI ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy NCT06580717Phase 41 site📍 Seoul Yonsei University · Tests: enavogliflozin 0.3mg, enavogliflozin Placebo Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy NCT07372196NA1 site📍 Novosibirsk Meshalkin Research Institute of Pathology of Circulation · Tests: ICD with left bundle branch area pacing (LBBAP), dual-chamber ICD Evaluation of HEArt invoLvement in Patients With FABRY Disease NCT03362164n/a1 site📍 Würzburg Wuerzburg University Hospital HCMR Re-Imaging Study NCT07054073n/a8 sites📍 Boston📍 Medford📍 Ann Arbor Christopher Kramer · Tests: None - observational study Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study. NCT06607471n/a1 site📍 Milan Scientific Institute San Raffaele · Tests: Support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation, Suppor… Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy NCT07600177Phase 42 sites📍 Kansas City📍 Portland Oregon Health and Science University · Tests: Aficamten US Benchmarking Clinical Study NCT07215715n/a3 sites📍 Boston📍 Boston📍 Boston eMyosound SAS MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies NCT06555237Phase 21 site📍 Warsaw Medical University of Warsaw · Tests: Trametinib tablet, Standard therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy